Search Results
Results found for "OMass Therapeutics"
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics
- Dr. Michael Feigin | Dr. GPCR Ecosystem
Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic
- Dr. Prasenjit Saha | Dr. GPCR Ecosystem
receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic
- Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem
neuronal circuits — insights that inform next-generation functional assay development and translational therapeutic
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic
- Dr. Michel Bouvier | Dr. GPCR Ecosystem
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- Session VIII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
GPCRs in the regulation of physiologic/pathologic function in the heart in an effort to uncover novel therapeutic
- Yamina's Corner | Dr. GPCR Ecosystem
Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic Abishek Iyer, CEO Ashta Therapeutics Before working with Yamina, we had solid internal momentum but needed
- FAQ | Dr. GPCR Ecosystem
Each session explores mechanistic models, translational challenges, and real-world therapeutic implications
- Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA; Division of Molecular Therapeutics, New York State
- GPCR Webinars | Dr. GPCR Ecosystem
Each session explores mechanistic models, translational challenges, and real-world therapeutic implications
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
By integrating advanced tools and translational biology, his work directly informs therapeutic strategies
- Our History | Dr. GPCR Ecosystem
Sep 20, 2022 — First contributor article published: Therapeutic validation of an orphan G protein‐coupled
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
analysis, revealed nuanced roles of RGS4, RGS9, and RGSZ — not just as modulators but as potential therapeutic
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
University of Copenhagen, Copenhagen, Denmark. (2) Department of Psychiatry and Molecular Pharmacology and Therapeutics Columbia University Vagelos College of Physicians and Surgeons, New York, USA; Division of Molecular Therapeutics
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
Clements' work is primarily focused on translational developments of small molecule therapeutics, and
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
graduate student, he worked in the EuGEF Research Group to identify novel prognostic biomarkers and therapeutic Clearly, a new, less toxic therapeutic is needed.
- Dr. John Janetzko | Dr. GPCR Ecosystem
Over the course of my graduate work, I gained experience with structural mass spectrometry and protein My postdoc work has made use of several techniques including various mass spectrometry approaches, single
- Revvity | Dr. GPCR Ecosystem
Whether you’re decoding signaling pathways or designing the next generation of therapeutics, Revvity
- Join the Dr. GPCR Affiliate Program - Empower the GPCR Community with Dr. GPCR Ecosystem Services
To be clear, commercializing, advertising, publishing, mass distributing, selling, or paying for the
- Content and Conduct Policy | Dr. GPCR Ecosystem
Spam Do not spam, including by sending unwanted promotional or commercial content, or mass solicitations
- Content Guidelines | Dr. GPCR Ecosystem
Spam Do not spam, including by sending unwanted promotional or commercial content, or mass solicitations













